Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,625 | -4,736 | -2,749 | -10,696 | -8,410 |
| Depreciation Amortization | 48 | 31 | 16 | 50 | 36 |
| Accounts receivable | -72 | 24 | 47 | -163 | -19 |
| Other Working Capital | -16 | 210 | 191 | 150 | 89 |
| Other Operating Activity | 5,484 | 2,620 | 1,626 | 6,768 | 5,253 |
| Operating Cash Flow | $-3,181 | $-1,851 | $-869 | $-3,891 | $-3,051 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -14 | N/A | -58 | -43 |
| Investing Cash Flow | $-27 | $-14 | $N/A | $-58 | $-43 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,335 | 1,825 | 920 | 1,535 | 1,310 |
| Common Stock Issued | 850 | 399 | 110 | 1,993 | 976 |
| Other Financing Activity | -495 | -300 | -300 | 114 | 357 |
| Financing Cash Flow | $4,690 | $1,924 | $730 | $3,642 | $2,643 |
| Exchange Rate Effect | -1 | -8 | -4 | -28 | -5 |
| Beginning Cash Position | 655 | 655 | 655 | 990 | 990 |
| End Cash Position | 2,136 | 706 | 512 | 655 | 534 |
| Net Cash Flow | $1,481 | $51 | $-143 | $-335 | $-456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,181 | -1,851 | -869 | -3,891 | -3,051 |
| Capital Expenditure | -27 | -14 | N/A | -58 | -43 |
| Free Cash Flow | -3,208 | -1,865 | -869 | -3,949 | -3,094 |